HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 134 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $611,200 | +61.4% | 16,000 | +52.4% | 0.01% | +50.0% |
| Q2 2023 | $378,735 | -95.3% | 10,500 | -95.0% | 0.00% | -95.2% |
| Q1 2023 | $8,019,900 | -33.0% | 210,000 | -0.2% | 0.08% | -33.6% |
| Q4 2022 | $11,977,450 | +1151.7% | 210,500 | +769.8% | 0.12% | +1036.4% |
| Q3 2022 | $956,868 | -27.3% | 24,200 | -26.7% | 0.01% | -8.3% |
| Q1 2022 | $1,316,000 | +1.3% | 33,000 | +2.2% | 0.01% | +33.3% |
| Q4 2021 | $1,299,000 | +46.4% | 32,300 | +48.2% | 0.01% | 0.0% |
| Q3 2021 | $887,000 | +226.1% | 21,800 | +263.3% | 0.01% | +200.0% |
| Q2 2021 | $272,000 | -70.3% | 6,000 | -72.7% | 0.00% | -66.7% |
| Q1 2021 | $917,000 | -50.5% | 22,000 | -49.3% | 0.01% | -52.6% |
| Q4 2020 | $1,854,000 | +63.6% | 43,400 | +0.7% | 0.02% | +46.2% |
| Q3 2020 | $1,133,000 | -30.3% | 43,100 | -28.9% | 0.01% | -31.6% |
| Q2 2020 | $1,625,000 | +148.1% | 60,600 | +66.5% | 0.02% | +111.1% |
| Q1 2020 | $655,000 | +29.2% | 36,400 | -8.8% | 0.01% | -10.0% |
| Q1 2014 | $507,000 | +40.8% | 39,900 | +66.2% | 0.01% | +42.9% |
| Q4 2013 | $360,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |